StemCell Institute Inc. (TYO:7096)
Japan
· Delayed Price · Currency is JPY 1,281.00
-24.00 (-1.84%)
May 12, 2025, 3:30 PM JST
StemCell Institute Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 3,532 | 2,845 | 3,324 | 3,511 | 2,743 | 3,024 | Upgrade
|
| Cash & Short-Term Investments | 3,532 | 2,845 | 3,324 | 3,511 | 2,743 | 3,024 | Upgrade
|
| Cash Growth | 31.11% | -14.41% | -5.33% | 28.00% | -9.29% | 22.73% | Upgrade
|
| Accounts Receivable | 1,806 | 1,584 | 1,137 | 593 | 280 | 278 | Upgrade
|
| Other Receivables | - | - | - | - | 64 | - | Upgrade
|
| Receivables | 1,806 | 1,584 | 1,137 | 593 | 344 | 278 | Upgrade
|
| Inventory | 49 | 42 | 39 | 40 | 32 | 16 | Upgrade
|
| Prepaid Expenses | 43 | 39 | 43 | 32 | 29 | 27 | Upgrade
|
| Other Current Assets | 50 | 5 | 2 | 2 | 2 | 3 | Upgrade
|
| Total Current Assets | 5,480 | 4,515 | 4,545 | 4,178 | 3,150 | 3,348 | Upgrade
|
| Property, Plant & Equipment | 636 | 665 | 648 | 647 | 576 | 106 | Upgrade
|
| Long-Term Investments | 974 | 1,178 | 411 | 203 | 195 | 79 | Upgrade
|
| Other Intangible Assets | 88 | 41 | 24 | 24 | 15 | 8 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 5 | 44 | 28 | 20 | 22 | Upgrade
|
| Other Long-Term Assets | 2 | 1 | 1 | 2 | 2 | 1 | Upgrade
|
| Total Assets | 7,180 | 6,543 | 5,811 | 5,215 | 3,958 | 3,564 | Upgrade
|
| Accounts Payable | 38 | 36 | 30 | 29 | 21 | 16 | Upgrade
|
| Accrued Expenses | 32 | 70 | 65 | 59 | 57 | 54 | Upgrade
|
| Current Portion of Leases | - | 2 | 1 | - | - | - | Upgrade
|
| Current Income Taxes Payable | 103 | 179 | 192 | 153 | 105 | 116 | Upgrade
|
| Other Current Liabilities | 3,829 | 3,473 | 3,143 | 2,810 | 2,405 | 2,115 | Upgrade
|
| Total Current Liabilities | 4,042 | 3,760 | 3,431 | 3,051 | 2,588 | 2,301 | Upgrade
|
| Long-Term Leases | - | 6 | 4 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 66 | 59 | 57 | 53 | 43 | 1 | Upgrade
|
| Total Liabilities | 4,503 | 3,852 | 3,513 | 3,112 | 2,636 | 2,305 | Upgrade
|
| Common Stock | 704 | 704 | 704 | 704 | 374 | 374 | Upgrade
|
| Additional Paid-In Capital | 589 | 589 | 589 | 589 | 259 | 259 | Upgrade
|
| Retained Earnings | 1,402 | 1,318 | 1,007 | 809 | 687 | 625 | Upgrade
|
| Comprehensive Income & Other | -18 | 80 | -2 | 1 | 2 | 1 | Upgrade
|
| Shareholders' Equity | 2,677 | 2,691 | 2,298 | 2,103 | 1,322 | 1,259 | Upgrade
|
| Total Liabilities & Equity | 7,180 | 6,543 | 5,811 | 5,215 | 3,958 | 3,564 | Upgrade
|
| Total Debt | 399 | 8 | 5 | - | - | - | Upgrade
|
| Net Cash (Debt) | 3,133 | 2,837 | 3,319 | 3,511 | 2,743 | 3,024 | Upgrade
|
| Net Cash Growth | 16.30% | -14.52% | -5.47% | 28.00% | -9.29% | 22.73% | Upgrade
|
| Net Cash Per Share | 305.76 | 276.87 | 323.91 | 693.28 | 563.58 | 621.31 | Upgrade
|
| Filing Date Shares Outstanding | 10.25 | 10.25 | 25.62 | 5.12 | 4.87 | 4.87 | Upgrade
|
| Total Common Shares Outstanding | 10.25 | 10.25 | 25.62 | 5.12 | 4.87 | 4.87 | Upgrade
|
| Working Capital | 1,438 | 755 | 1,114 | 1,127 | 562 | 1,047 | Upgrade
|
| Book Value Per Share | 261.26 | 262.62 | 89.71 | 410.56 | 271.62 | 258.68 | Upgrade
|
| Tangible Book Value | 2,589 | 2,650 | 2,274 | 2,079 | 1,307 | 1,251 | Upgrade
|
| Tangible Book Value Per Share | 252.67 | 258.62 | 88.77 | 405.88 | 268.54 | 257.03 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.